HIV vaccines 1983-2003. (Q35166836)

6 August 2017

1 reference

title

HIV vaccines 1983-2003. (English)

1 reference

6 August 2017

author

Andrew James McMichael

series ordinal

1

object named as

Andrew J McMichael

1 reference

6 August 2017

Tomas Hanke

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

9

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

874-880

1 reference

The challenge of viral reservoirs in HIV-1 infection

6 August 2017

cites work

1 reference

7 January 2021

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

1 reference

7 January 2021

T cell responses and viral escape

1 reference

7 January 2021

Immune control of HIV: the obstacles of HLA and viral diversity

1 reference

7 January 2021

HIV-1 superinfection despite broad CD8 T-cell responses containing replication of the primary virus

1 reference

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

7 January 2021

Assessing animal models of AIDS.

1 reference

7 January 2021

Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment

1 reference

7 January 2021

Role of CD8( ) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

1 reference

7 January 2021

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

7 January 2021

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

7 January 2021

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

1 reference

7 January 2021

Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virus

1 reference

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

7 January 2021

Immunization and challenge of chimpanzees with HIV-1

1 reference

7 January 2021

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

1 reference

7 January 2021

Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers

1 reference

7 January 2021

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

1 reference

7 January 2021

Antibody neutralization and escape by HIV-1

1 reference

7 January 2021

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

7 January 2021

Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development

1 reference

7 January 2021

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

7 January 2021

Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies

1 reference

7 January 2021

Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission?

1 reference

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

7 January 2021

A role for carbohydrates in immune evasion in AIDS.

1 reference

7 January 2021

A formalin-inactivated whole SIV vaccine confers protection in macaques

1 reference

7 January 2021

Anti-cell antibody in macaques

1 reference

7 January 2021

Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques

1 reference

7 January 2021

Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor

1 reference

7 January 2021

Analysis of total human immunodeficiency virus (HIV)-specific CD4( ) and CD8( ) T-cell responses: relationship to viral load in untreated HIV infection

1 reference

7 January 2021

Vigorous HIV-1-specific CD4 T cell responses associated with control of viremia

1 reference

7 January 2021

HIV preferentially infects HIV-specific CD4 T cells

1 reference

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

7 January 2021

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

7 January 2021

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

7 January 2021

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

7 January 2021

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1 reference

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

7 January 2021

Evolution and transmission of stable CTL escape mutations in HIV infection

1 reference

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

7 January 2021

Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection

1 reference

7 January 2021

Cytotoxic T-lymphocyte escape monitoring in simian immunodeficiency virus vaccine challenge studies

1 reference

7 January 2021

Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?

1 reference

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8 T cells

1 reference

7 January 2021

Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

1 reference

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

7 January 2021

Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen

1 reference

7 January 2021

Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: involvement of IFN-gamma.

1 reference

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

7 January 2021

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

1 reference

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

7 January 2021

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

1 reference

7 January 2021

Human immunodeficiency virus infection among high-risk seronegative prostitutes in Nairobi

1 reference

7 January 2021

AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa

1 reference

7 January 2021

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

7 January 2021

CD8( ) lymphocytes respond to different HIV epitopes in seronegative and infected subjects

1 reference

7 January 2021

Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8 responses

1 reference

7 January 2021

Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

1 reference

7 January 2021

Direct visualization of antigen-specific CD8 T cells during the primary immune response to Epstein-Barr virus In vivo

1 reference

7 January 2021

Virus-specific CD8 cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

7 January 2021

Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection.

1 reference

7 January 2021

Dynamics of T cell responses in HIV infection

1 reference

7 January 2021

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

1 reference

7 January 2021

Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys.

1 reference

7 January 2021

Enhanced immunogenicity for CD8 T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

7 January 2021

A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.

1 reference

7 January 2021

Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene

1 reference

7 January 2021

A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus

1 reference

7 January 2021

Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

1 reference

7 January 2021

Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120.

1 reference

7 January 2021

Diversity considerations in HIV-1 vaccine selection

1 reference

7 January 2021

The quest for an AIDS vaccine: is the CD8 T-cell approach feasible?

1 reference

7 January 2021

T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen

1 reference

7 January 2021

Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines

1 reference

7 January 2021

Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study

1 reference

7 January 2021

A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques

1 reference

7 January 2021

Rapid effector function in CD8 memory T cells

1 reference

7 January 2021

Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines

1 reference

7 January 2021

Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus

1 reference

7 January 2021

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

1 reference

7 January 2021

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya

1 reference

7 January 2021

HIV-1-specific CD4 T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

7 January 2021

T cell death and memory

1 reference

7 January 2021

Stimulation of memory T cells by cytokines

1 reference

7 January 2021

Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin

1 reference

7 January 2021

Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle

1 reference

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

7 January 2021

Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding

1 reference

7 January 2021

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

7 January 2021

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

1 reference

7 January 2021

Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.

1 reference

7 January 2021

Dramatic rise in plasma viremia after CD8( ) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8 lymphocytes

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM0703-874

1 reference

6 August 2017

1 reference